Bischoff SC, Boirie Y, Cederholm T, Chourdakis M, Cuerda C, Delzenne NM, et al. Towards a multidisciplinary approach to understand and manage obesity and related diseases. Clin Nutr. 2017;36:917–38.
Google Scholar
Chu DT, Minh Nguyet NT, Dinh TC, Thai Lien NV, Nguyen KH, Nhu Ngoc VT, et al. An update on physical health and economic consequences of overweight and obesity. Diabetes Metab Syndr. 2018;12:1095–100.
Google Scholar
Fruh SM. Obesity: risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29:S3–s14.
Google Scholar
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
Google Scholar
Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220–9.
Google Scholar
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the american heart association. Circulation. 2021;143:e984–e1010.
Google Scholar
Donini LM, Merola G, Poggiogalle E, Lubrano C, Gnessi L, Mariani S, et al. Disability, physical inactivity, and impaired health-related quality of life are not different in metabolically healthy vs. unhealthy obese subjects. Nutrients. 2016;8:759.
Okifuji A, Hare BD. The association between chronic pain and obesity. J Pain Res. 2015;8:399–408.
Google Scholar
Stephenson J, Smith CM, Kearns B, Haywood A, Bissell P. The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study. BMC Public Health. 2021;21:1990.
Google Scholar
Pan A, Kawachi I, Luo N, Manson JE, Willett WC, Hu FB, et al. Changes in body weight and health-related quality of life: 2 cohorts of US women. Am J Epidemiol. 2014;180:254–62.
Google Scholar
Sarwer DB, Polonsky HM. The psychosocial burden of obesity. Endocrinol Metab Clin North Am. 2016;45:677–88.
Google Scholar
Avila C, Holloway AC, Hahn MK, Morrison KM, Restivo M, Anglin R, et al. An overview of links between obesity and mental health. Curr Obes Rep. 2015;4:303–10.
Google Scholar
Brewis AA. Stigma and the perpetuation of obesity. Soc Sci Med. 2014;118:152–8.
Google Scholar
Fulton M, Dadana S, Srinivasan VN Obesity, Stigma, and Discrimination. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Sriharsha Dadana declares no relevant financial relationships with ineligible companies. Disclosure: Vijay Srinivasan declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024.
Jiwanmall SA, Kattula D, Nandyal MB, Parvathareddy S, Kirubakaran R, Jebasingh F, et al. Weight stigma in patients with obesity and its clinical correlates: a perspective from an indian bariatric clinic. Cureus. 2022;14:e26837.
Google Scholar
Okunogbe A, Nugent R, Spencer G, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for eight countries. BMJ Global Health. 2021;6:e006351.
Tackling obesities: future choices—project report 2nd Edition. 2007.
Horn DB, Almandoz JP, Look M. What is clinically relevant weight loss for your patients and how can it be achieved? A narrative review. Postgrad Med. 2022;134:359–75.
Google Scholar
Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22:1–203.
Google Scholar
Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes. 2016;40:1310–9.
Google Scholar
Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95:297–308.
Google Scholar
Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. lancet Diabetes Endocrinol. 2016;4:913–21.
Google Scholar
Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes. 2021;45:1249–58.
Google Scholar
Centre for Public Health Excellence at N, National Collaborating Centre for Primary C. National Institute for Health and Clinical Excellence: Guidance. Obesity: The Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. London: National Institute for Health and Clinical Excellence (UK) Copyright © 2006, National Institute for Health and Clinical Excellence.; 2006.
Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:S102–38.
Google Scholar
Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481–6.
Google Scholar
Cefalu WT, Bray GA, Home PD, Garvey WT, Klein S, Pi-Sunyer FX, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2015;38:1567–82.
Google Scholar
Singh M, Lee J, Gupta N, Gaddam S, Smith BK, Wani SB, et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity. 2013;21:284–90.
Google Scholar
Lv N, Xiao L, Ma J. Weight management interventions in adult and pediatric asthma populations: a systematic review. J Pulmonary Respir Med. 2015;5:1000232.
Haufe S, Haas V, Utz W, Birkenfeld AL, Jeran S, Böhnke J, et al. Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. Diabetes Care. 2013;36:3786–92.
Google Scholar
Varkevisser RDM, van Stralen MM, Kroeze W, Ket JCF, Steenhuis IHM. Determinants of weight loss maintenance: a systematic review. Obes Rev. 2019;20:171–211.
Google Scholar
Williamson DA, Bray GA, Ryan DH. Is 5% weight loss a satisfactory criterion to define clinically significant weight loss? Obesity. 2015;23:2319–20.
Google Scholar
England PH Better Health campaign Phase 1: evaluation of the NHS weight loss plan app. 2021.
Tate DF, Turner-McGrievy G, Lyons E, Stevens J, Erickson K, Polzien K, et al. Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. Am J Clin Nutr. 2012;95:555–63.
Google Scholar
Toon J, Geneva M, Sharpe P, Lavin J, Bennett S, Avery A. Weight loss outcomes achieved by adults accessing an online programme offered as part of Public Health England’s ‘Better Health’ campaign. BMC Public Health. 2022;22:1456.
Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Google Scholar
Alfadda AA, Al-Naami MY, Masood A, Elawad R, Isnani A, Ahamed SS, et al. Long-term weight outcomes after bariatric surgery: a single center saudi arabian cohort experience. J Clin Med. 2021;10:4922.
O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29:3–14.
Google Scholar
Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA Surg. 2018;153:427–34.
Google Scholar
Team TE. EndNote. Clarivate: Philadelphia, PA. 2023.
O’Mara-Eves A, Kneale D A critical appraisal tool for assessing research on purchasing (point of sales) data. In: Unpublished manuscript SSRULE-C, UCL Institute of Education., editor. 2019.
Programme CAS. CASP Randomised Controlled Trial Checklist. Online2023 Available from: https://casp-uk.net/casp-tools-checklists/.
Abbenhardt C, McTiernan A, Alfano CM, Wener MH, Campbell KL, Duggan C, et al. Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med. 2013;274:163–75.
Google Scholar
Ahmad Zamri L, Appannah G, Zahari Sham SY, Mansor F, Ambak R, Mohd Nor NS, et al. Weight change and its association with cardiometabolic risk markers in overweight and obese women. J Obes. 2020;2020:3198326.
Google Scholar
Ahn SY, Kim DK, Han SS, Park JH, Shin SJ, Lee SH, et al. Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease. Kidney Res Clin Pract. 2018;37:49–58.
Google Scholar
Bays H, Pi-Sunyer X, Hemmingsson JU, Claudius B, Jensen CB, Van Gaal L. Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects. Curr Med Res Opin. 2017;33:225–9.
Google Scholar
Campbell KL, Foster-Schubert KE, Alfano CM, Wang C-C, Wang C-Y, Duggan CR, et al. Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol. 2012;30:2314–26.
Google Scholar
D’Alonzo NJ, Qiu L, Sears DD, Chinchilli V, Brown JC, Sarwer DB, et al. WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Insulin and Insulin Resistance in Breast Cancer Survivors. Nutrients. 2021;13:3108.
Davidson MH, Tonstad S, Oparil S, Schwiers M, Day WW, Bowden CH. Changes in Cardiovascular Risk Associated With Phentermine and Topiramate Extended-Release in Participants With Comorbidities and a Body Mass Index ≥27 kg/m2. Am J Cardiol. 2013;111:1131–8.
Google Scholar
Del Ben M, Angelico F, Cangemi R, Loffredo L, Carnevale R, Augelletti T, et al. Moderate weight loss decreases oxidative stress and increases antioxidant status in patients with metabolic syndrome. ISRN Obes. 2012;2012:960427.
Google Scholar
Harrigan M, Cartmel B, Loftfield E, Sanft T, Chagpar AB, Zhou Y, et al. Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, Exercise, and Nutrition (LEAN) Study. J Clin Oncol. 2016;34:669–76.
Google Scholar
Konerman MA, Walden P, Joseph M, Jackson EA, Lok AS, Rubenfire M. Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease. Alimentary Pharmacol Therapeut. 2019;49:296–307.
Google Scholar
Lang HF, Chou CY, Sheu WH, Lin JY. Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m². Nutr Res. 2011;31:378–86.
Google Scholar
Magkos F, Nikonova E, Fain R, Zhou S, Ma T, Shanahan W. Effect of lorcaserin on glycemic parameters in patients with type 2 diabetes mellitus. Obesity. 2017;25:842–9.
Google Scholar
Maruthur NM, Ma Y, Delahanty LM, Nelson JA, Aroda V, White NH, et al. Early response to preventive strategies in the Diabetes Prevention Program. J Gen Intern Med. 2013;28:1629–36.
Google Scholar
Miazgowski T, Kaczmarkiewicz A, Miazgowski B, Kopeć J. Cardiometabolic health, visceral fat and circulating irisin levels: results from a real-world weight loss study. J Endocrinol Investig. 2021;44:1243–52.
Google Scholar
Muramoto A, Matsushita M, Kato A, Yamamoto N, Koike G, Nakamura M, et al. Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan. Obes Res Clin Pract. 2014;8:e466–75.
Google Scholar
Nagahara M, Higuchi Y, Akatsu J, Tani N, Yamamoto R, Ohta M. Verification of the effects of three percent weight loss at 6 months and application possibility of assessment at 3 months after the specific health guidance for male workers. Sangyo Eiseigaku Zasshi J Occup health. 2021;63:86–94.
Google Scholar
Rintamäki R, Rautio N, Peltonen M, Jokelainen J, Keinänen-Kiukaanniemi S, Oksa H, et al. Long-term outcomes of lifestyle intervention to prevent type 2 diabetes in people at high risk in primary health care. Prim Care Diabetes. 2021;15:444–50.
Google Scholar
Shirai K, Saiki A, Oikawa S, Teramoto T, Yamada N, Ishibashi S, et al. The effects of partial use of formula diet on weight reduction and metabolic variables in obese type 2 diabetic patients-multicenter trial. Obes Res Clin Pract. 2013;7:e43–54.
Google Scholar
Strelitz J, Ahern AL, Long GH, Hare MJL, Irving G, Boothby CE, et al. Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality. Diabetologia. 2019;62:1391–402.
Google Scholar
Thibault V, Morisset AS, Brown C, Carpentier AC, Baillargeon JP, Langlois MF, et al. The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function. Br J Nutr. 2015;114:161–8.
Google Scholar
Vetter ML, Wadden TA, Chittams J, Diewald LK, Panigrahi E, Volger S, et al. Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial. Int J Obes. 2013;37:S19–24.
Google Scholar
Dittus KL, Harvey JR, Bunn JY, Kokinda ND, Wilson KM, Priest J, et al. Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors. BMC Cancer. 2018;18:351.
Google Scholar
Dong TS, Luu K, Lagishetty V, Sedighian F, Woo SL, Dreskin BW, et al. The intestinal microbiome predicts weight loss on a calorie-restricted diet and is associated with improved hepatic steatosis. Front Nutr. 2021;8:718661.
Google Scholar
Duggan C, de Dieu Tapsoba J, Mason C, Imayama I, Korde L, Wang CY, et al. Effect of Vitamin D3 supplementation in combination with weight loss on inflammatory biomarkers in postmenopausal women: a randomized controlled trial. Cancer Prev Res. 2015;8:628–35.
Google Scholar
Gomez-Huelgas R, Ruiz-Nava J, Santamaria-Fernandez S, Vargas-Candela A, Alarcon-Martin AV, Tinahones FJ, et al. Impact of intensive lifestyle modification on levels of adipokines and inflammatory biomarkers in metabolically healthy obese women. Mediators Inflamm. 2019;2019:4165260.
Google Scholar
Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol. 1992;36:105–11.
Google Scholar
Kolehmainen M, Salopuro T, Schwab US, Kekäläinen J, Kallio P, Laaksonen DE, et al. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int J Obes. 2008;32:292–303.
Google Scholar
Kosiborod MN, Bhatta M, Davies M, Deanfield JE, Garvey WT, Khalid U, et al. Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes Obes Metab. 2023;25:468–78.
Google Scholar
Mason C, Xiao L, Imayama I, Duggan CR, Campbell KL, Kong A, et al. The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: a randomized controlled trial. Clin Endocrinol. 2015;82:369–76.
Google Scholar
Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, et al. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care. 2008;31:1416–21.
Google Scholar
Rock CL, Pande C, Flatt SW, Ying C, Pakiz B, Parker BA, et al. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese. Clin Breast Cancer. 2013;13:188–95.
Google Scholar
Spurny M, Jiang Y, Sowah SA, Schübel R, Nonnenmacher T, Bertheau R, et al. Changes in bone marrow fat upon dietary-induced weight loss. Nutrients. 2020;12:1509.
Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Blair SN, Church TS. Effects of clinically significant weight loss with exercise training on insulin resistance and cardiometabolic adaptations. Obesity. 2016;24:812–9.
Google Scholar
Swift DL, Houmard JA, Slentz CA, Kraus WE. Effects of aerobic training with and without weight loss on insulin sensitivity and lipids. PLoS ONE. 2018;13:e0196637.
Google Scholar
Christian JG, Byers TE, Christian KK, Goldstein MG, Bock BC, Prioreschi B, et al. A computer support program that helps clinicians provide patients with metabolic syndrome tailored counseling to promote weight loss. J Am Dietetic Assoc. 2011;111:75–83.
Google Scholar
Grandi Silva A, Duarte Freitas P, Ferreira PG, Stelmach R, Carvalho-Pinto RM, Salge JM, et al. Effects of weight loss on dynamic hyperinflation in obese women asthmatics. J Appl Physiol. 2019;126:413–21.
Google Scholar
Habermann N, Makar KW, Abbenhardt C, Xiao L, Wang CY, Utsugi HK, et al. No effect of caloric restriction or exercise on radiation repair capacity. Med Sci Sports Exerc. 2015;47:896–904.
Google Scholar
Höchsmann C, Dorling JL, Martin CK, Newton RL Jr, Apolzan JW, Myers CA, et al. Effects of a 2-year primary care lifestyle intervention on cardiometabolic risk factors: a cluster-randomized trial. Circulation. 2021;143:1202–14.
Google Scholar
Ashley JM, St Jeor ST, Schrage JP, Perumean-Chaney SE, Gilbertson MC, McCall NL, et al. Weight control in the physician’s office. Arch Intern Med. 2001;161:1599–604.
Google Scholar
Chang HM, Lee HJ, Park HS, Kang JH, Kim KS, Song YS, et al. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity. 2010;18:2105–10.
Google Scholar
Johnson WD, Brashear MM, Gupta AK, Rood JC, Ryan DH. Incremental weight loss improves cardiometabolic risk in extremely obese adults. Am J Med. 2011;124:931–8.
Google Scholar
Kaholokula JK, Townsend CK, Ige A, Sinclair K, Mau MK, Leake A, et al. Sociodemographic, behavioral, and biological variables related to weight loss in native Hawaiians and other Pacific Islanders. Obesity. 2013;21:E196–203.
Google Scholar
Nadinskaia M, Maevskaya M, Ivashkin V, Kodzoeva K, Pirogova I, Chesnokov E, et al. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2021;27:959–75.
Google Scholar
Sharma AM, Caterson ID, Coutinho W, Finer N, Van Gaal L, Maggioni AP, et al. Blood pressure changes associated with sibutramine and weight management – an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT). Diabetes Obes Metab. 2009;11:239–50.
Google Scholar
Muls E, Kolanowski J, Scheen A, Van Gaal L. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Int J Obes Relat Metab Disord. 2001;25:1713–21.
Google Scholar
Poppitt SD, Keogh GF, Prentice AM, Williams DE, Sonnemans HM, Valk EE, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr. 2002;75:11–20.
Google Scholar
Falchi AG, Grecchi I, Muggia C, Tinelli C. Weight loss and P wave dispersion: a preliminary study. Obes Res Clin Pract. 2014;8:e614–7.
Google Scholar
Alfaris N, Wadden TA, Sarwer DB, Diwald L, Volger S, Hong P, et al. Effects of a 2-year behavioral weight loss intervention on sleep and mood in obese individuals treated in primary care practice. Obesity. 2015;23:558–64.
Google Scholar
Chang M-W, Tan A, Schaffir J, Wegener DT. Sleep and weight loss in low-income overweight or obese postpartum women. BMC Obes. 2019;6:12.
Google Scholar
Patrick DL, Bushnell DM, Rothman M. Performance of two self-report measures for evaluating obesity and weight loss. Obes Res. 2004;12:48–57.
Google Scholar
Vasiljevic N, Ralevic S, Kolotkin RL, Marinkovic J, Jorga J. The relationship between weight loss and health-related quality of life in a Serbian population. Eur Eat Disord Rev. 2012;20:162–8.
Google Scholar
Wing RR, Creasman JM, West DS, Richter HE, Myers D, Burgio KL, et al. Improving urinary incontinence in overweight and obese women through modest weight loss. Obstet Gynecol. 2010;116:284–92.
Google Scholar
Georgoulis M, Yiannakouris N, Kechribari I, Lamprou K, Perraki E, Vagiakis E, et al. Dose-response relationship between weight loss and improvements in obstructive sleep apnea severity after a diet/lifestyle interventions: secondary analyses of the “MIMOSA” randomized clinical trial. J Clin Sleep Med. 2022;18:1251–61.
Google Scholar
Kolotkin RL, Norquist JM, Crosby RD, Suryawanshi S, Teixeira PJ, Heymsfield SB, et al. One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures. Health Qual Life Outcomes. 2009;7:53.
Google Scholar
Messier V, Rabasa-Lhoret R, Doucet E, Brochu M, Lavoie JM, Karelis A, et al. Effects of the addition of a resistance training programme to a caloric restriction weight loss intervention on psychosocial factors in overweight and obese post-menopausal women: a Montreal Ottawa New Emerging Team study. J Sports Sci. 2010;28:83–92.
Google Scholar
Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res. 2012;72:2314–26.
Google Scholar
Duggan C, Tapsoba JD, Wang CY, Campbell KL, Foster-Schubert K, Gross MD, et al. Dietary weight loss, exercise, and oxidative stress in postmenopausal women: a randomized controlled trial. Cancer Prev Res. 2016;9:835–43.
Google Scholar
Aller R, Izaola O, Gómez S, Tafur C, González G, Berroa E, et al. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. Eur Rev Med Pharmacol Sci. 2015;19:3118–24.
Google Scholar
Rusu E, Jinga M, Enache G, Rusu F, Dragomir AD, Ancuta I, et al. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C-a randomized trial. Nutr J. 2013;12:119.
Google Scholar
St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. J Gastroenterol Hepatol. 2009;24:399–407.
Google Scholar
Annesi JJ, Stewart FA. Contrasts of initial and gain scores in obesity treatment-targeted psychosocial variables by women participants’ weight change patterns over 2 years. Fam Community Health. 2023;46:39–50.
Google Scholar
Sheng JY, Santa-Maria CA, Blackford AL, Lim D, Carpenter A, Smith KL, et al. The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote. J Cancer Survivorship. 2022;16:542–51.
Google Scholar
Tseng MC, Lee YJ, Chen SY, Lee MB, Lin KH, Chen PR, et al. Psychobehavioral response and weight loss prediction in a hospital-based weight reduction program. J Formos Med Assoc. 2002;101:705–11.
Google Scholar
Wu CH, Kuo HC, Chang CS, Yu C. What extent of weight loss can benefit the health-related quality of life in motivated obese Chinese? Asia Pac J Clin Nutr. 2009;18:423–32.
Google Scholar
Jouneau S, Crestani B, Thibault R, Lederlin M, Vernhet L, Valenzuela C, et al. Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis. Respir Res. 2020;21:312.
Google Scholar
Scott HA, Gibson PG, Garg ML, Pretto JJ, Morgan PJ, Callister R, et al. Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomized trial. Clin Exp Allergy. 2013;43:36–49.
Google Scholar
Bartoskova Polcrova A, Dalecka A, Szabo D, Gonzalez Rivas JP, Bobak M, Pikhart H. Social and environmental stressors of cardiometabolic health. Sci Rep. 2024;14:14179.
Google Scholar
Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and Over. Curr Obes Rep. 2017;6:187–94.
Google Scholar
Zomer E, Gurusamy K, Leach R, Trimmer C, Lobstein T, Morris S, et al. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes Rev. 2016;17:1001–11.
Google Scholar
Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41:459–71.
Google Scholar
Bray GA, Ryan DH. Evidence-based weight loss interventions: Individualized treatment options to maximize patient outcomes. Diabetes Obes Metab. 2021;23:50–62.
Google Scholar
Packer J, Croker H, Goddings AL, Boyland EJ, Stansfield C, Russell SJ, et al. Advertising and young people’s critical reasoning abilities: systematic review and meta-analysis. Pediatrics. 2022;150:e2022057780.
Global BMIMC, Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388:776–86.
Google Scholar
Ells LJ, Ashton M, Li R, Logue J, Griffiths C, Torbahn G, et al. Can we deliver person-centred obesity care across the globe? Curr Obes Rep. 2022;11:350–5.
Google Scholar
Smith SR, Stenlof KS, Greenway FL, McHutchison J, Schwartz SM, Dev VB, et al. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial. Obesity. 2011;19:1796–803.
Google Scholar
link